APA (7th ed.) Citation

Alaa M. Ghallab, Reda A. Eissa, & Hend M. El Tayebi. (2022). CXCR2 Small-Molecule Antagonist Combats Chemoresistance and Enhances Immunotherapy in Triple-Negative Breast Cancer. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Alaa M. Ghallab, Reda A. Eissa, and Hend M. El Tayebi. CXCR2 Small-Molecule Antagonist Combats Chemoresistance and Enhances Immunotherapy in Triple-Negative Breast Cancer. Frontiers Media S.A., 2022.

MLA (9th ed.) Citation

Alaa M. Ghallab, et al. CXCR2 Small-Molecule Antagonist Combats Chemoresistance and Enhances Immunotherapy in Triple-Negative Breast Cancer. Frontiers Media S.A., 2022.